Cargando…

A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms

Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yong, Gao, Hao, Wang, Guangfu, Yin, Lingdi, Xu, Wenbin, Peng, Yunpeng, Wu, Junli, Jiang, Kuirong, Miao, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940798/ https://www.ncbi.nlm.nih.gov/pubmed/29739948 http://dx.doi.org/10.1038/s41598-018-24072-0

Ejemplares similares

Risk Factors of the Recurrences of Pancreatic Solid Pseudopapillary Tumors: A Systematic Review and Meta-analysis
por: Gao, Hao, et al.
Publicado: (2018)

Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms
por: Xu, Wenbin, et al.
Publicado: (2021)

Risk factors of delayed gastric emptying in patients after pancreaticoduodenectomy: a comprehensive systematic review and meta-analysis
por: Dai, Shangnan, et al.
Publicado: (2023)

Higher miR‐543 levels correlate with lower STK31 expression and longer pancreatic cancer survival
por: Yuan, Weizhong, et al.
Publicado: (2020)

The distinct genetic features of pancreatic cancer in Chinese population
por: Yin, Lingdi, et al.
Publicado: (2022)

Cancer‐testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer
por: Gao, Hao, et al.
Publicado: (2022)

Insulin promotes invasion and migration of KRAS(G12D) mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling
por: Wang, Guangfu, et al.
Publicado: (2019)

CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer
por: Yin, Lingdi, et al.
Publicado: (2022)

Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer
por: Zhu, Xiaole, et al.
Publicado: (2022)

Perioperative safety and prognosis following parenchyma-preserving surgery for solid pseudopapillary neoplasm of the pancreas
por: Gao, Yong, et al.
Publicado: (2023)

Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms
por: Kurita, Yusuke, et al.
Publicado: (2022)

Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China
por: Yin, Lingdi, et al.
Publicado: (2022)

Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
por: Gao, Yong, et al.
Publicado: (2021)

Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Undifferentiated Carcinoma of Pancreas with Osteoclast-Like Giant Cells: One Center’s Experience of 13 Cases and Characteristic Pre-Operative Images
por: Gao, Yong, et al.
Publicado: (2022)

Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram
por: Zhou, Shengnan, et al.
Publicado: (2021)

Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer
por: Liu, Xinchun, et al.
Publicado: (2018)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
por: Bevere, Michele, et al.
Publicado: (2023)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Black pleural effusion due to pancreatic pseudocyst: A case report
por: Guo, Feng, et al.
Publicado: (2017)

Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm
por: Yang, Zhi-hao, et al.
Publicado: (2023)

From “step-up” to “step-jump”: a leap-forward intervention for infected necrotizing pancreatitis
por: Huang, Dongya, et al.
Publicado: (2022)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

Transcriptional Profiling Reveals the Regulatory Role of DNER in Promoting Pancreatic Neuroendocrine Neoplasms
por: He, Rui, et al.
Publicado: (2020)

Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC
por: Wang, Guangfu, et al.
Publicado: (2021)

Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020)

Current update on imaging for pancreatic neuroendocrine neoplasms
por: Segaran, Nicole, et al.
Publicado: (2021)

Advances in medical treatment for pancreatic neuroendocrine neoplasms
por: Li, Yuan-Liang, et al.
Publicado: (2022)

Reconsideration of operative indications in pancreatic neuroendocrine neoplasms
por: Abe, Kodai, et al.
Publicado: (2022)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

Clinical Usefulness of Plasma Chromogranin A in Pancreatic Neuroendocrine Neoplasm
por: Paik, Woo Hyun, et al.
Publicado: (2013)

Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
por: Li, Yongzheng, et al.
Publicado: (2022)

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023)

Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
por: Hijioka, Susumu, et al.
Publicado: (2014)

Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms
por: Tong, Zhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hqn9o1hbullusjt9b5vb99g0op